![]() |
市場調查報告書
商品編碼
1889252
發酵機能性食品市場預測至2032年:按產品、成分類別、功能性益處、標籤檢視、最終用戶和地區分類的全球分析Fermented Functional Foods Market Forecasts to 2032 - Global Analysis By Product, Ingredient Category, Functional Benefit, Label Claim, End User and By Geography |
||||||
根據 Stratistics MRC 的研究,預計到 2025 年,全球發酵機能性食品市場規模將達到 429 億美元,到 2032 年將達到 836 億美元,預測期內複合年成長率為 10%。
發酵機能性食品是透過可控微生物發酵製成的營養豐富的食品,除了基本的營養價值外,還具有促進健康的功效。在發酵過程中,有益細菌、酵母或真菌會分解食物成分,產生益生菌、有機酸、胜肽和酵素等生物活性化合物,有助於維持健康的腸道環境、支持免疫功能並促進整體健康。這類食品具有更高的消化率、更強的營養生物利用度和天然的防腐特性。典型的例子包括優格、Kefir、泡菜、酸菜、康普茶、Tempeh和味噌。發酵機能性食品結合了傳統的發酵過程和功能性健康益處,在均衡營養、維持消化系統健康和促進健康的腸道菌叢方面發揮重要作用。
消費者對腸道環境的興趣日益濃厚
富含益生菌的食品,如優格、Kefir、康普茶和泡菜,因其有益消化器官系統受到追捧。消費者越來越意識到腸道菌叢與整體健康之間的聯繫,從而推動了市場需求。支持免疫功能、促進新陳代謝和營養吸收的機能性食品在已開發市場和新興市場都越來越受歡迎。零售商和品牌商正在重新設計產品,以突出益生菌含量和「潔淨標示」的宣傳。社群媒體和健康領域的意見領袖進一步提高了人們對腸道健康益處的認知。因此,消費者對腸道健康越來越感興趣,從而推動了市場成長。
高昂的生產和加工成本
發酵機能性食品需要專門的培養技術、可控的環境和先進的加工流程來確保品質和安全。這些成本遠高於傳統食品生產。小規模生產商難以與能夠承擔更高成本的成熟品牌競爭。發展中地區對價格敏感的消費者不太可能接受高價發酵產品。益生菌菌株複雜的供應鏈也進一步加重了生產者的經濟負擔。
人們對益生菌益處的認知不斷提高
消費者越來越意識到益生菌在改善消化功能、免疫力和提升整體健康方面的重要作用。宣傳宣傳活動和科學研究正在增強消費者對益生菌機能性食品的信任。肥胖和糖尿病等文明病的日益增多,加速了人們對腸道健康營養的需求。各國政府和醫療機構正在推廣益生菌攝入,將其作為預防保健策略的一部分。配方技術的進步也使得開發更有效、更美味的益生菌產品成為可能。
關於健康聲明的監管挑戰
許多地區在核准益生菌相關的健康聲明之前,都要求進行廣泛的臨床檢驗,這延緩了產品的商業化進程,並給生產商帶來了不確定性。中小企業往往缺乏進行大規模試驗的資源,從而限制了它們的競爭力。各國法規的不一致進一步加劇了進入全球市場的困難。當健康聲明受到限制或意義不明時,消費者的疑慮也會隨之增加。
新冠疫情對發酵機能性食品市場產生了複雜的影響。供應鏈中斷導致原料供應困難,生產週期延長,進而延後了部分地區的上市時間。疫情期間,經濟的不確定性導致消費者對高階機能性食品的支出下降。然而,人們對免疫力和消化健康的日益關注,重新燃起了對富含益生菌產品的興趣。線上超市和電商平台加速了消費者對透明、安全食品的需求。製造商也積極回應,在產品定位中強調天然成分和健康益處。
預計在預測期內,發酵乳製品細分市場將佔據最大的市場佔有率。
預計在預測期內,發酵乳製品將佔據最大的市場佔有率,這主要得益於消費者對優格、Kefir和益生菌飲品的強勁需求。乳製品發酵產品因其促進消化和增強免疫力的功效而廣受認可。消費者對機能飲料和零食的需求不斷成長,推動了發酵乳製品的普及。製造商正透過研發潔淨標示配方和推出無乳糖產品來拓展消費群。零售商店和電商平台的廣泛佈局也促進了發酵乳製品的普及。人們對腸道健康的日益關注與乳製品益生菌的益處不謀而合。
預計在預測期內,合益素細分市場將實現最高的複合年成長率。
預計在預測期內,合益素和益生元組合製劑將呈現最高的成長率,反映出市場對這類產品的強勁需求。合益素透過支持有益菌及其生存環境,能更有效地促進腸道健康。消費者對先進消化解決方案的日益青睞,正在加速該領域的市場成長。製造商正投資研發創新配方,以提高合益素產品的功效和適口性。健康意識日益增強的零售和電商通路的強勁成長,也推動了該領域的蓬勃發展。合益素功效的科學檢驗更增強了消費者的信心。
由於健康意識的增強以及消費者對發酵食品的文化接受度較高,預計亞太地區在預測期內將保持最大的市場佔有率。中國、印度、日本和韓國等國對富含益生菌的產品需求強勁。不斷壯大的中產階級和日益成長的可支配收入推動了高級產品的普及。消費者對發酵食品的傳統消費習慣增強了對天然配方的信任。政府推行的促進健康和預防保健的措施進一步加速了發酵食品的普及。本土生產商正在加大對潔淨標示和機能性食品創新的投資。
由於健康意識的提高和對優質營養品需求的成長,預計中東和非洲地區在預測期內將實現最高的複合年成長率。阿拉伯聯合大公國、沙烏地阿拉伯和南非等國的益生菌機能性食品的普及率正在不斷提高。零售連鎖店和電子商務平台的擴張推動了對透明天然產品的需求。政府為促進食品安全和健康所採取的措施進一步加速了這一趨勢。可支配收入的增加和都市化也促進了高級產品的消費。為了滿足這一新興需求,當地Start-Ups公司和跨國公司正在投資合益素創新技術。
According to Stratistics MRC, the Global Fermented Functional Foods Market is accounted for $42.9 billion in 2025 and is expected to reach $83.6 billion by 2032 growing at a CAGR of 10% during the forecast period. Fermented functional foods are nutrient-rich products created through controlled microbial fermentation that enhances their health-promoting properties beyond basic nutrition. During fermentation, beneficial bacteria, yeasts, or fungi break down food components to produce bioactive compounds such as probiotics, organic acids, peptides, and enzymes that support gut health, immunity, and overall well-being. These foods offer improved digestibility, increased nutrient bioavailability, and natural preservation. Examples include yogurt, kefir, kimchi, sauerkraut, kombucha, tempeh, and miso. By combining traditional fermentation processes with functional health benefits, fermented functional foods play an important role in promoting balanced nutrition, digestive health, and a resilient microbiome.
Rising consumer focus on gut health
Probiotic-rich foods such as yogurt, kefir, kombucha, and kimchi are increasingly sought after for their digestive benefits. Consumers are becoming more aware of the link between gut microbiota and overall wellness, reinforcing demand. Functional foods that support immunity, metabolism, and nutrient absorption are gaining traction in both developed and emerging markets. Retailers and brands are reformulating products to highlight probiotic content and clean-label claims. Social media and health influencers further amplify awareness of gut health benefits. As a result, consumer focus on gut health is propelling market growth.
High production and processing costs
Fermented functional foods require specialized cultures, controlled environments, and advanced processing technologies to ensure quality and safety. These costs are significantly higher compared to conventional food production. Smaller manufacturers struggle to compete with established brands that can absorb higher expenses. Price-sensitive consumers in developing regions are less likely to adopt premium fermented products. Complex supply chains for probiotic strains further add to the financial burden.
Increasing awareness of probiotic benefits
Consumers are recognizing the role of probiotics in improving digestion, immunity, and overall health. Educational campaigns and scientific studies are reinforcing trust in probiotic-based functional foods. Rising prevalence of lifestyle diseases such as obesity and diabetes is accelerating demand for gut-friendly nutrition. Governments and healthcare organizations are promoting probiotic consumption as part of preventive healthcare strategies. Advances in formulation technologies are enabling more effective and palatable probiotic products.
Regulatory challenges for health claims
Many regions require extensive clinical validation before approving probiotic-related health claims. This slows commercialization and creates uncertainty for manufacturers. Smaller firms often lack resources to conduct large-scale trials, limiting their competitive edge. Regulatory inconsistencies across countries further complicate global market penetration. Consumer skepticism increases when health claims are restricted or unclear.
The COVID-19 pandemic had a mixed impact on the Fermented Functional Foods market. Supply chain disruptions affected ingredient availability and delayed production schedules, slowing adoption in several regions. Economic uncertainty reduced consumer spending on premium functional foods during the crisis. However, heightened awareness of immunity and digestive health drove renewed interest in probiotic-rich products. Online grocery and e-commerce platforms accelerated demand for transparent and safe food options. Manufacturers adapted by emphasizing natural ingredients and health benefits in product positioning.
The fermented dairy segment is expected to be the largest during the forecast period
The fermented dairy segment is expected to account for the largest market share during the forecast period, driven by strong consumer preference for yogurt, kefir, and probiotic drinks. Dairy-based fermented products are widely recognized for their digestive and immune-supporting benefits. Rising demand for functional beverages and snacks reinforces adoption of fermented dairy. Manufacturers are innovating with clean-label formulations and lactose-free options to expand consumer reach. The segment benefits from strong retail and e-commerce presence, making fermented dairy widely accessible. Growing awareness of gut health aligns directly with the benefits of dairy-based probiotics.
The synbiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the synbiotics segment is predicted to witness the highest growth rate , reflecting strong demand for combined probiotic and prebiotic formulations. Synbiotics enhance gut health more effectively by supporting both beneficial bacteria and their growth environment. Rising consumer preference for advanced digestive solutions accelerates adoption in this segment. Manufacturers are investing in innovative formulations to improve efficacy and palatability of synbiotic products. The segment benefits from strong growth in wellness-focused retail and e-commerce channels. Scientific validation of synbiotic benefits further amplifies consumer trust.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising health awareness and strong cultural acceptance of fermented foods. Countries such as China, India, Japan, and South Korea are witnessing strong demand for probiotic-rich products. Expanding middle-class populations and growing disposable incomes support premium product adoption. Traditional consumption of fermented foods reinforces consumer trust in natural formulations. Government initiatives promoting wellness and preventive healthcare further accelerate adoption. Local manufacturers are increasingly investing in clean-label and functional food innovations.
Over the forecast period, the Middle East & Africa region is anticipated to exhibit the highest CAGR by rising health awareness and growing demand for premium nutrition, the Middle East & Africa region is anticipated to exhibit the highest CAGR over the forecast period. Countries such as UAE, Saudi Arabia, and South Africa are increasingly adopting probiotic-rich functional foods. Expanding retail chains and e-commerce platforms reinforce demand for transparent and natural products. Government initiatives promoting food safety and wellness further accelerate adoption. Rising disposable incomes and urbanization support premium product consumption. Local startups and multinational firms are investing in synbiotic innovations to capture emerging demand.
Key players in the market
Some of the key players in Fermented Functional Foods Market include Nestle, Danone, Yakult Honsha Co. Ltd., PepsiCo, The Coca-Cola Company, General Mills, Kellogg's, Unilever, Mondelez International, Lifeway Foods, GT's Living Foods, Bio-K Plus International, Chobani LLC, Fonterra Co-operative Group and Arla Foods.
In March 2024, Danone launched its new "Fermented Foods by Danone" platform in March 2024, prominently featuring a line of savory fermented vegetables like kimchi and sauerkraut under the Happy Gut Pro brand in Europe. This launch directly expands their functional food portfolio beyond dairy-based probiotics, tapping into the growing consumer demand for diverse, gut-healthy fermented options.
In April 2023, Nestle Health Science completed the acquisition of a majority stake in Vowst(TM), a novel FDA-approved oral microbiome therapeutic for preventing recurrent C. difficile infection, from Seres Therapeutics. This strategic move, finalized in April 2023, marked a significant push beyond food into clinically proven, fermented microbiome-based medicines, positioning Nestle at the forefront of gut health innovation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.